Carta Healthcare, the leader in enterprise clinical data management, today announced Lighthouse for Oncology. Health systems can now apply Carta Healthcare's Hybrid Intelligence approach to cancer ...

Results reveal familiarity with potential workflow benefits, although concerns about human oversight and quality remain SAN FRANCISCO, Feb. 11, 2025 /PRNewswire/ -- The vast majority of clinical data ...

The round was led by Origin Ventures with participation from InnovateHealth Ventures, 25madison, Next Play Ventures, 2048 Ventures, Alumni Ventures, and strategic angels The Century Health Abstraction ...

The central promise of precision medicine is to provide right-sized and personalized care, patient by patient, instead of hewing to a singular clinical pathway for all patients who have a particular ...

For all its promise, artificial intelligence has risk. And hospitals, health systems and group practices need to proceed with caution, says Betsy Castillo, RN, vice president of clinical data ...

Interview on Ontada research presented at ISPOR 2024. Use of real-world data in research demands that data pulled from electronic health records are accurate. New research from Ontada shows how doing ...

Manual extraction of case details from patient records for cancer surveillance is a resource-intensive task. Natural Language Processing (NLP) techniques have been proposed for automating the ...

SAN FRANCISCO, March 24, 2026 /PRNewswire/ -- Carta Healthcare, the award-winning leader in enterprise clinical data management, today announced it has been named a winner in the 2026 Artificial ...

Forbes contributors publish independent expert analyses and insights. That momentum continues today with the announcement of a $21 million Series A by Layer Health, an ambitious healthcare AI startup ...

AI-enabled clinical data abstraction company Carta Healthcare has scored $18.25 million in Series B1 financing led by UPMC Enterprises. New investors MemorialCare Innovation Fund, Tampa General ...

“The gold standard is not the perfect test but merely the best available test… gold standards are constantly challenged and superseded when appropriate.” 1 Clinical trials remain an indispensable tool ...